Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8240140 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 10 Pages |
Abstract
Celecoxib enhanced radiosensitivity by inhibition of EGFR-mediated mechanisms of radioresistance, a signaling that was independent of COX-2 activity. This novel observation may have therapeutic implications such that COX-2 inhibitors may improve therapeutic efficacy of radiation even in patients whose tumor radioresistance is not dependent on COX-2.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Klaus H. Ph.D., Claus Mayer, Petra A. Ph.D., Uma Ph.D., Nickolaus H. M.D., Luka M.D., Ph.D., H. Peter Ph.D.,